My watch list
my.bionity.com  
Login  

51 Newest Publications about the topic hemophilia

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Y‐chromosome identification in circulating cell‐free fetal DNA using surface plasmon resonance

06-Feb-2016 | Giulia Breveglieri, Elisabetta Bassi, Silvia Carlassara, Lucia Carmela Cosenza, Patrizia Pellegatti, Giovanni Guerra ..., Prenatal Diagnosis, 2016

Abstract Objective Since the discovery of cell‐free fetal DNA (cffDNA) in maternal plasma, diagnostic non‐invasive prenatal methods have been developed or optimized for fetal sex determination and identification of genetic diseases. As far as fetal sex determination, this might be important ...

more

Synergistic inhibition of PARP‐1 and NF‐κB signaling down‐regulates immune response against recombinant AAV2 vectors during hepatic gene therapy

07-Oct-2015 | Sangeetha Hareendran, Banumathi Ramakrishna, Giridhara R. Jayandharan, European Journal of Immunology, 2015

Host immune response remains a key obstacle to widespread application of AAV based gene therapy. Thus, targeted inhibition of the signaling pathways that trigger such immune responses will be beneficial. Previous studies have reported that DNA damage response proteins such as PARP‐1 negatively ...

more

Regulation of a strong F9 cryptic 5′ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides

01-Sep-2015 | Dario Balestra; Elena Barbon; Daniela Scalet; Nicola Cavallari; Daniela Perrone; Silvia Zanibellato; Francesco Berna ..., Human Molecular Genetics, 2015

Mutations affecting specific splicing regulatory elements offer suitable models to better understand their interplay and to devise therapeutic strategies. Here we characterize a meaningful splicing model in which numerous Hemophilia B-causing mutations, either missense or at the donor splice site ...

more

Personalized approaches to the treatment of hemophilia A and B

03-Aug-2015 | Vijaya L Simhadri; Aditi Sengupta Banerjee; Jonathan Simon; Chava Kimchi-Sarfaty; Zuben E Sauna, Personalized Medicine, 2015

The recognition that individuals respond differently to the same medication is not new and dates almost to the founding of western medicine. In the last century it came to be recognized that genetic factors influence the heterogeneity of individual responses to medications with respect to both ...

more

Personalized approaches to the treatment of hemophilia A and B

03-Aug-2015 | Vijaya L Simhadri; Aditi Sengupta Banerjee; Jonathan Simon; Chava Kimchi-Sarfaty; Zuben E Sauna, Personalized Medicine, 2015

The recognition that individuals respond differently to the same medication is not new and dates almost to the founding of western medicine. In the last century it came to be recognized that genetic factors influence the heterogeneity of individual responses to medications with respect to both ...

more

Exposure of FVIII in the Presence of Phosphatidyl Serine Reduces Generation of Memory B‐Cells and Induces Regulatory T‐Cell‐Mediated Hyporesponsiveness in Hemophilia A Mice

03-Jun-2015 | Radha Ramakrishnan, Andrew Davidowitz, Sathy V. Balu‐Iyer, Journal of Pharmaceutical Sciences, 2015

A major complication of replacement therapy with Factor VIII (FVIII) for hemophilia A (HA) is the development of unwanted immune responses. Previous studies showed that administration of FVIII in the presence of phosphatidyl serine (PS) reduced the development of anti‐FVIII antibodies in HA ...

more

Turoctocog alfa for hemophilia A

23-Mar-2015 | Drug Design, Development and Therapy, 2015

Takedani H, Hirose J

more

Intravenous administration of Factor VIII–O-Phospho-L-Serine (OPLS) complex reduces immunogenicity and preserves pharmacokinetics of the therapeutic protein

26-Oct-2014 | Author(s): Puneet Gaitonde , Vivek S. Purohit , Sathy V. Balu-Iyer, European Journal of Pharmaceutical Science, 2014

Publication date: Available online 20 October 2014 Source:European Journal of Pharmaceutical Sciences Author(s): Puneet Gaitonde , Vivek S. Purohit , Sathy V. Balu-Iyer Hemophilia A is a bleeding disorder caused by the deficiency of an important coagulation factor; Factor VIII (FVIII). ...

more

The extraordinary career of Professor Dr. Simon van Creveld

30-Sep-2014 | Paul J. W. Stoelinga, Walter E. Berdon, M. Michael Cohen, American Journal of Medical Genetics Part A, 2014

Simon van Creveld received both the MD and PhD degrees and had a multifaceted medical and scientific education at many hospitals and research institutes in the Netherlands, Germany, and the UK. He and his wife were the first to develop insulin for the Netherlands. His major interests were in ...

more

O‐Phospho‐l‐Serine mediates Hyporesponsiveness toward FVIII in Hemophilia A‐Murine Model by Inducing Tolerogenic Properties in Dendritic Cells

30-Sep-2014 | Anas M. Fathallah, Radha Ramakrishnan, Sathy V. Balu‐Iyer, Journal of Pharmaceutical Sciences, 2014

The clinical use of therapeutic proteins can be complicated by the development of anti‐product antibodies. We have previously observed that O‐phospho‐l‐serine (OPLS) reduced antibody response to FVIII in Hemophilia‐A (HA) mice. However, the mechanism underlying this observation is not clear. We ...

more

Page 1 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE